Endra signs binding merger agreement with ASP Isotopes and partners
Endra Life Sciences signed a merger agreement with ASP Isotopes, Renergen, and Noble Africa to combine their businesses into a single entity. This strategic combination aims to leverage the mutual strengths of the two companies in the medical and isotope markets.
View filing at SEC.gov →